DPS fusion proteins for use in vaccines and diagnostics
US9241986B2 · kind B2 · utility
2Cited by
1References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Dec 22, 2010 |
| Grant date | Jan 26, 2016 |
| Priority date | — |
| Expiry date | Jan 15, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2760/16122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel nanoparticle fusion proteins comprising proteins or peptides fused to Dps (DNA-binding protein from starved cells) proteins are provided which bring forth distinct advantages for development of new and improved vaccines, diagnostic tests, and other biomedical products.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.